Tag Archives: fundraising campaign

LSN Summer Reading Series, Chapter 14: “Thirty-One Tips for Effective Fundraising”

27 Aug

By Michael Quigley, Director of Research, LSN

mike-2

To bring LSN’s Life Science Executive’s Fundraising Manifesto toward a close, we provide some motivational advice and tactical reminders to help a fundraising CEO bring their outbound campaign to a successful resolution.

With illustrations and helpful mottos, this ‘cheat sheet’ chapter will help the reader find their way through the fundraising maze in good spirits. From how to stay optimistic during the tough times, to when to stop marketing to investors, this chapter has it covered.

Click here to download/print the chapter PDF

Join us next week for the book’s addendum: “The View Beyond Venture Capital.”

Enjoyed the preview? Buy now from Amazon.com or Barnes & Noble

Bookcover-Front

 

Your Target List: Who Is Not Investing

3 Jul

By Michael Quigley, Director of Research, LSN

mike-2

As a fundraising entrepreneur, knowing who is actively investing and who is not has the potential to increase the efficiency of your campaign by 30%, if not more.

Who is “not currently allocating” is one of the most valuable data points that we gather on the life science investment community. In this category we put any investor who has made investments in the space over the past five years and is in the process of fundraising, winding down a fund, or moving out of the space completely. Of the investors we have spoken to over the past year, we have found that approximately 30% are not currently looking to make new investments.

Why is this important? Because investors who aren’t allocating tend to be the slowest to respond to emails and voicemails, which can mean weeks—if not months—of wasted effort, as you try again and again to reach investors that are not seeking opportunities.

When we analyzed our data further, things got even more interesting. Of the investors we have spoken with who are not currently allocating, two-thirds are VCs; of the investors who are allocating, only one-third are VCs. This demonstrates a point we have discussed in this newsletter before: a large number of previously active life science VC investors are now raising their own funds, winding down, or phasing out of the life science sector.

The bottom line is that by knowing who is not actively allocating, you can identify all the players in your space who are seeking opportunities and substantially increase the efficiency and likelihood of successfully raising capital.  Too often fundraising executives use a shotgun approach, reaching out and trying to touch everyone who may or may not be investing in their space. This tactic creates a lot of needless noise and wasted time for both parties. A little extra knowledge regarding the current state of the targeted investor can go a long way toward making a fundraising executive much more productive in seeking capital.

Developing a Global Target List of Prospective Investors

17 Oct
By Max Klietmann, VP of Marketing, LSN

Before moving any further, it is important to address a critical piece of the equation while looking at structuring an institutional-style fundraising campaign. The issue of referral vs. fit is one of the most misunderstood parts of the fundraising process, and countless companies fail to raise money, simply because their fundraising executives won’t believe that a cold email can be effective. We at LSN speak to a lot of entrepreneurs who refuse to accept that outbound marketing works, and it is our belief that this is due to an unwillingness to commit rather than genuine disbelief. Once you have made the commitment to go outbound, things become a little easier.

On to the issue of the cold e-mail. It has been proven time and time again that cold emails with diligent follow-up targeting the right group can be extremely effective. This is primarily because cold emails help you to reach the target person – with cold emails you can immediately reach exactly the right people in the investor organization, and that makes a significant difference. Of course this won’t work with just a random list of emails, you need a targeted list of specific entities. Beyond that, you need to reach the right people, not just the right firms.

Now that we’ve covered that, let’s look at the potential pool of investors and narrow it down to a target list. There are two types of investors: mandate-driven and opportunistic. Mandate driven investors are usually restricted to investing in opportunities that match a particular main sector, subsector, development phase, growth phase, indication preference, capital structure or need above or below a certain amount of investment. These restrictions are formed at the inception of the fund in order to provide serve as unique investment vehicle that matches the investment interests of the limited partner’s participating in the fund. By limiting the investment opportunities the limited partners can benefit from the unique risk and reward characteristics of the fund. For example an investor might specialize in investing in late stage oncology opportunities that requires equity financing. As a result opportunities outside of the mandate’s scope are immediately disqualified. Opportunistic investors on the other hand are defined by their lack of a mandate driven investment strategy. As a result they will not disqualify opportunities and therefore tend to have a broad range of investments.

As a fundraising executive you must understand each investor’s investment criteria, and make an effort to target those that are a match your company’s unique investment profile. Otherwise, you will find yourself wasting your time reaching out to investors that are not a fit. Note however, that your list should not be restricted to only fits for your current round, as you want to create a dialogue with investors that will be a fit further down the road. That way, when the next fundraising hurdle is reached, you already have a dialogue with the next source of capital.

Here’s a good benchmark to use: for every 100 investors that you reach out that that are un-validated without any clear indication of potential fit, a hit rate of 1-2 is the absolute upper limit. However, of a list of 100 investors with a pre-validated declared interest in an opportunity like yours, one should expect to schedule a conference call or meeting with 15–20 of those prospects. This is in stark contrast to the one or two prospects that you will yield from a un-targeted list. Assuming you are able to obtain a vetted target list and you’ve taken the time to evaluate your resources for follow-up, you can now get an idea of how many investors you will need on your email target list.

Generally, a fundraising executive starts be mining their internal database of potential investors—a list of current, past, and prospective investors—which they have built up over the years. This is a start, but your work is not done. To augment such a list, you can purchase one of the hundreds of commercially available databases, or take some time to research potential investors on your own.

Researching investors on your own is time consuming process, and painful process. Sophisticated investor database providers on the other hand can provide you with a list of potential investors that meet your investment profile with a couple clicks. They do this by employing staff that actively interviews investors regarding their investment preferences. Although these providers charge a fee they can save you significant time and effort.